LFLourdes Flores-Luna

Lourdes Flores-Luna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lourdes Flores-Luna has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of social isolation and loneliness by living arrangement among Mexican elderly during the Covid-19 pandemic

    by Ana Laura Rodríguez-Vázquez, Rocío Rodríguez-Valentín, Lourdes Flores-Luna, Angélica Ángeles-Llerenas, Eduardo Lazcano-Ponce

    Objective. To estimate the prevalence of social isolation (SI) and loneliness by sociodemographic, information and communication technologies use, health behavior, and health status among Mexican older adults (OA) living alone (LA) and those living with others (LWO) during the Covid-19 pandemic. Materials and methods. Data from the Encuesta Nacional de Salud y Nutrición Continua 2021 conducted in Mexico were analyzed. SI and loneliness were measured using internationally validated scales (LSNS-6 and TILS respectively). Analyses were conducted on adults aged 65 years and older, LA and LWO, considering the survey design. Results. Approximately 30% of OA in Mexico were LA in 2021. Among those LA, the percentage of widowhood, low well-being index and suicidal ideation were higher than in those LWO. SI prevalence was similarly high among individuals LA and those LWO (81.1 and 81.9% respectively), while loneliness prevalence was higher among individuals LA (51.5%) compared to those LWO (35.4%). Some differences in the characteristics of OA with higher prevalences of SI and loneliness were observed between those LA and those LWO. Conclusion. Targeted interventions are needed to address SI and loneliness in OA, based on whether they are LA or LWO, while considering the vulnerabilities of each living arrangement.


  • Open Access

    Prevalencia de factores de riesgo cardiometabólico en México, Ensanut 2021

    by Lourdes Flores-Luna, Rosalba Rojas-Martínez, Consuelo Escamilla-Núñez, Lilia Castro-Porras, Leticia Hernández Cadena, Martín Romero-Martínez, Carlos A Aguilar-Salinas

    Objetivo. Determinar la prevalencia de factores de riesgo cardiometabólico (FRCM) en adultos, por sexo y tamaño de localidad para proporcionar evidencia que apoye la planificación de programas preventivos y de atención de enfermedades cardiometabólicas. Material y métodos. Se analizaron datos de 1 880 adultos de 20 años o más participantes en la Encuesta Nacional de Salud y Nutrición Continua 2021, estudio representativo a nivel nacional y por localidad. Los análisis consideraron el diseño complejo de la encuesta. Resultados. La obesidad abdominal fue el FRCM más prevalente, el cual afectó a 74% de hombres y 88% de las mujeres. Entre las mujeres, 63% presentó hipoalfalipoproteinemia, 60% colesterol LDL elevado y 32% de las de 40 a 59 años presentó entre 6 y 11 FRCM. En los hombres, 52% mostró hipertrigliceridemia, 51% C-LDL elevado, y 29% de los de 40 a 59 años presentó de 6 a 11 FRCM. Por localidad, los hombres rurales mostraron mayor prevalencia de C-LDL elevado (70%) y las mujeres urbanas niveles bajos de C-HDL. Conclusión. Los resultados evidencian diferencias por sexo y tamaño de localidad en las prevalencias de los FRCM y la necesidad de estrategias preventivas diferenciadas.


  • Open Access

    Estado nutricional de personas adultas mayores usuarias de centros gerontológicos en la Ciudad de México

    by Beatriz Nava Baltazar, Ma de Lourdes Guadalupe Flores Luna, Manuel Palacios Martínez, María Del Carmen Salazar Jiménez, José Mario González

    Actualmente la información existente sobre el estado de nutrición de las personas adultas mayores usuarias de instituciones de asistencia es escasa. El objetivo de este estudio transversal analítico es evaluar el estado nutricional de las personas adultas mayores usuarias de albergues y residencias de día del Instituto Nacional de las Personas Adultas Mayores en la Ciudad de México. Material y métodos: La población seleccionada para este estudio fueron las personas adultas mayores de 60 años de ambos sexos, usuarias de los albergues y residencias de día del Instituto Nacional de las Personas Adulta Mayores (INAPAM) de la Ciudad de México, la información se obtuvo mediante el análisis de los expedientes médicos. Resultados: La población de estudio incluyo a 127 personas adultas mayores, de los cuales el 46.5% son residentes de albergues y 53.5% usuarios de residencias de día del Instituto Nacional de las Personas Adultas Mayores en la CDMX. Respecto al estado nutricional, 48.1% de la población total presenta malnutrición, de los cuales 54.3% son residentes de albergues y 42.7% usuarios de residencias de día. Discusión: se identificaron como factores de riesgo (relacionados estadísticamente) para presentar malnutrición el deterioro cognitivo, dependencia en las actividades básicas de la vida diaria, el modelo fue ajustado por edad, sexo y polifarmacia, y se encontró que las personas residentes de albergues y con deterioro cognitivo tienen más posibilidades de presentar malnutrición.

  • Open Access

    Detection of Epstein-Barr Virus DNA in Gastric Biopsies of Pediatric Patients with Dyspepsia

    by Abigail Morales-Sánchez, Javier Torres, María G. Cardenas-Mondragón, Carolina Romo-González, Margarita Camorlinga-Ponce, Lourdes Flores-Luna, Ezequiel M. Fuentes-Pananá

    In this study, we assessed the presence of Epstein-Barr virus (EBV) in gastric samples derived from pediatric patients with dyspeptic symptoms, aiming to understand whether EBV participates in the development of early gastric lesions influencing chronic inflammation, in conjunction with the Helicobacter pylori (Hp) bacterium. We analyzed EBV load in 236 gastric biopsies derived from 186 pediatric patients with chronic dyspepsia and compared it with EBV serology, Hp load and serology, and with immune cell infiltration. We found that 7.5% of patients were positive for EBV load, ranging from 240 to 29,685 genomic copies/μg of DNA. Hp genomic sequences were found in 24.7% of patients. EBV positive samples did not correlate with Hp status and were characterized by absent to moderate immune cell infiltration. To our knowledge, this is the first study addressing EBV load in the stomach in a large cohort of pediatric patients with dyspeptic symptoms, providing evidence of EBV localization in the gastric mucosa in early inflammatory lesions. The lack of correlation between EBV and both Hp infection and inflammation is perhaps explained by independent pathogenic mechanisms or because of the randomness of the gastritis sampling. This is also supported by a moderate association between EBV load and serology.


  • Provider delay in treatment initiation and its influence on survival outcomes in women with operable breast cancer

    by Christian H. Flores-Balcázar, Ma. L. Flores-Luna, Cynthia M. Villarreal-Garza, Juan E. Bargalló-Rocha

    The goal of this study was to determine whether a delay in starting treatment via surgery or neoadjuvant chemotherapy is related to a decrease in cancer-specific survival (CSS) in women with operable breast cancer (BrCr). Limited medical infrastructure and a lack of cancer prevention awareness in low- and middle-income countries have caused high BrCr incidence and mortality rates. We analyzed a retrospective cohort of 720 women treated at a single center from 2005 to 2012. CSS estimates were obtained by the Kaplan-Meier method. A Cox model of proportional risks was performed to obtain the risk of dying from BrCr. We also obtained the risk according to the category of treatment initiation. Women with locally advanced stages and without hormone receptor expression were more likely to initiate treatment after 45 days. Patients in Stage IIIA had a 78.1% survival if treatment was initiated before 45 days (95% CI, 0.70-0.84) and 63.6% survival if treatment was started after 45 days (95% CI, 0.44-0.78; p < 0.001). Patients in Stage IIIB had a 62.9% survival if treatment was initiated before 45 days (95% CI, 0.53-0.72) and 57.4% survival if treatment started after 45 days (95% CI, 0.31-0.89; p < 0.001). Prognostic factors in which lower survival was recognized were Stage IIIA, Stage IIIB, treatment initiation after 45 days, and triple-negative tumors. The initiation of treatment within the first 45 days of diagnosis of BrCr in women portends better survival compared with those who began treatment longer than 45 days from diagnosis.


  • Synergistic action of folate intake and testosterone associated with breast cancer risk

    by Luisa María Sánchez-Zamorano, Angélica Angeles-Llerenas, Aaron Salinas-Rodríguez, Eduardo C. Lazcano-Ponce, Isabelle Romieu, Edelmiro Pérez-Rodríguez, Lourdes Flores-Luna, Gabriela Torres-Mejía


  • Open Access

    Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer

    by Christian H. Flores-Balcázar, Lourdes Flores-Luna, Cynthia Villarreal-Garza, Aida Mota-García, Enrique Bargalló-Rocha

    Our objective was to determine whether a delay in adjuvant radiotherapy is related to a decrease in relapse-free survival and disease-specific survival of women with operable breast cancer. Data on 1000 patients diagnosed with breast cancer were recorded. The cohort was divided into five groups according to the timing of radiotherapy: ≤30 days, 31 to 60 days, 61 to 90 days, 91 to 120 days, and >120 days. The relapse-free survival and disease-specific survival were also calculated in relation to the number of patients. This study found no statistical difference for delays in adjuvant radiotherapy in patients with early breast cancer, but we noted a statistical decrease in disease-specific survival in patients with locally advanced breast cancer receiving radiotherapy after a delay of at least 60 days. Waiting times for radiotherapy should be as short as reasonably achievable, given the specific risk factors in the individual patient.